Prakt. lékáren. 2016; 12(1): 6-11 [Klin Farmakol Farm. 2015;29(3):95-99]

What are the current options for affecting immunity in routine clinical practice?

Jaromír Bystroň
Oddělení alergologie a klinické imunologie Fakultní nemocnice Olomouc

The author presents an overview of the current options of immunomodulatory therapy in routine clinical practice. They are divided into products that are used primarily for anti-inflammatory therapy, immunosubstitution and immunostimulation. Also addressed is the current status of OTC products for „stimulation of immunity“ from the perspective of evidence-based medicine.

Keywords: anti-inflammatory therapy, immunosubstitution, immunostimulation

Published: February 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bystroň J. What are the current options for affecting immunity in routine clinical practice? Praktické lékárenství. 2016;12(1):6-11.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Současné možnosti imunomodulační léčby v praxi. Farmakoterapautické informace 12/2004; 12: 3-4, 2005; 1: 1-2.
    2. Bystroň J. Moderní antihistaminika v klinické praxi. Postgraduální medicína 2015; 17(3): 273-276.
    3. Bystroň J. Novinky v imunomodulaci bakteriálními imunomodulátory. Alergie 2013; 15: 264-268.
    4. Bystroň J. Bakteriální imunomodulátory - současné použití v klinické praxi. Remedia, 2010; 20(5): 298-305.
    5. Bystroň J. Možnosti imunomodulační léčby při řešení recidivujících infekcí dýchacích ces., Medicina pro praxi: 2013; 10(1): 16-21.
    6. Jeseňák M, Rennerová Z, Bánovčin P, a kol. Recidivujúce infekcie dýchacích ciest a imunomodulácia u detí. 2012; Eds. Aeskulap, Mladá fronta.
    7. Adámková E, Balcar J, Bartovičová E, a kol. Systémová enzymoterapie v komplexní léčbě recidivujících zánětů dýchacích cest u dětí - postregistrační retrospektivní multicentrické hodnocení. Čes.-slov. Pediatrie 2004: 59(1): 513-521.
    8. Unzeitig V, Dvořák V, Hlaváčková O, a kol. Systémová enzymoterapie v léčbě recidivující vulvovaginální kandidózy. Čes. Gynek., 2013; 78(2): 187-194.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.